The Federal Trade Commission (FTC) joined four states in filing a lawsuit Wednesday against the World Professional Association for Transgender Health (WPATH) for alleged deceptive practices regarding the treatment of children suffering from gender dysphoria.
The complaint, which was filed in the U.S. District Court for the Northern District of Texas and joined by Alaska, Iowa, Nebraska and Texas, alleges that the world's leading association for transgender medicine made false and unsubstantiated claims to parents to sell pediatric medical transition services for their children, including drugs and surgery.
"When an entity makes a claim about a medical treatment, the claim must be truthful, evidence-based and not misleading," FTC Chairman Andrew Ferguson said in a press release. "Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services. For decades, the FTC has taken action against entities that make deceptive and unsubstantiated health-related claims."
"The complaint filed today reflects that same long-standing mandate: when an entity makes a claim about a medical treatment, the claim must be truthful, evidence-based and not misleading," Ferguson added.
The complaint accuses WPATH, which the FTC described as "an association of clinicians who profit from pediatric medical transition services," of violating the FTC Act by misleading parents and their children about the medical consensus and necessity of transgender procedures, as well as their safety and effectiveness.
FTC sues WPATH for deceptive practices regarding children | Politics
No comments:
Post a Comment